Drug therapy: Multidisciplinary management of lung cancer

[31] SYMPTOM RELIEF WITH MVP (MITOMYCIN-C, VINBLASTINE AND CISPLATIN) CHEMOTHERAPY IN ADVANCED NON-SMALL-CELL LUNG-CANCER [J]. BRITISH JOURNAL OF CANCER, 1995, 71 (02) : 366 - 370

[32] Is there a preferred combination chemotherapy regimen for metastastic non-small cell lung cancer? [J]. ONCOLOGIST, 2002, 7 (03) : 226 - 233

[33] Molecular pathogenesis of lung cancer [J]. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1999, 118 (06) : 1136 - 1152

[34] Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens [J]. JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (12) : 2354 - 2362

[35] Cisplatin, gemcitabine, and paclitaxel in locally advanced or metastatic non-small-cell lung cancer: A phase I-II study [J]. JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (08) : 2316 - 2325

[36] RANDOMIZED TRIAL OF CYCLOPHOSPHAMIDE, DOXORUBICIN, AND VINCRISTINE VERSUS CISPLATIN AND ETOPOSIDE VERSUS ALTERNATION OF THESE REGIMENS IN SMALL-CELL LUNG-CANCER [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1991, 83 (12) : 855 - 861

[37] Fukuoka M., 2002, P AN M AM SOC CLIN, V21, p298a

[38] Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer [J]. JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (09) : 2692 - 2699

[39] A multidisciplinary surgical approach to superior sulcus tumors with vertebral invasion [J]. ANNALS OF THORACIC SURGERY, 1999, 68 (05) : 1778 - 1785

[40] Phase III comparative study of high-dose cisplatin versus a combination of paclitaxel and cisplatin in patients with advanced non-small-cell lung cancer [J]. JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (19) : 3390 - 3399

[31] SYMPTOM RELIEF WITH MVP (MITOMYCIN-C, VINBLASTINE AND CISPLATIN) CHEMOTHERAPY IN ADVANCED NON-SMALL-CELL LUNG-CANCER [J]. BRITISH JOURNAL OF CANCER, 1995, 71 (02) : 366 - 370

[32] Is there a preferred combination chemotherapy regimen for metastastic non-small cell lung cancer? [J]. ONCOLOGIST, 2002, 7 (03) : 226 - 233

[33] Molecular pathogenesis of lung cancer [J]. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1999, 118 (06) : 1136 - 1152

[34] Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens [J]. JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (12) : 2354 - 2362

[35] Cisplatin, gemcitabine, and paclitaxel in locally advanced or metastatic non-small-cell lung cancer: A phase I-II study [J]. JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (08) : 2316 - 2325

[36] RANDOMIZED TRIAL OF CYCLOPHOSPHAMIDE, DOXORUBICIN, AND VINCRISTINE VERSUS CISPLATIN AND ETOPOSIDE VERSUS ALTERNATION OF THESE REGIMENS IN SMALL-CELL LUNG-CANCER [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1991, 83 (12) : 855 - 861

[37] Fukuoka M., 2002, P AN M AM SOC CLIN, V21, p298a

[38] Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer [J]. JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (09) : 2692 - 2699

[39] A multidisciplinary surgical approach to superior sulcus tumors with vertebral invasion [J]. ANNALS OF THORACIC SURGERY, 1999, 68 (05) : 1778 - 1785

[40] Phase III comparative study of high-dose cisplatin versus a combination of paclitaxel and cisplatin in patients with advanced non-small-cell lung cancer [J]. JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (19) : 3390 - 3399